Katri Lindfors

Activities

Activities per year 2003 2009 2010 2011 2012 2013 2019 2022

• 172 Conference presentation
• 29 Reviewer of Scientific Journal
• 14 Supervisor of master student
• 7 Supervisor of doctoral candidate
• 41 More
  • 7 Invited lecture
  • 6 Pre-examination of dissertation or acting as opponent to doctoral students
  • 5 Regular membership of a society or network
  • 5 Position of trust in a funding organization
  • 4 Media appearance
  • 3 Supervisor of licentiate candidate in medicine
  • 2 Chair of workshop, panel, session or tutorial
  • 2 Membership of an organizing committee of a conference or seminar
  • 2 Public talk
  • 1 Membership of a scientific or program committee of a conference or seminar
  • 1 Consultancy
  • 1 Position of trust in a society or network
  • 1 Academic qualification (e.g. title of docent)
  • 1 Leadership of a scientific program or project

Activities per year

Search results

• Polycomb regulates the intestinal stem cell niche - aberrancies implicated in celiac disease

  Mikko Oittinen (Contributor), Kalle Kurppa (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor), Alina Popp (Contributor) & Keijo Viiri (Contributor)

  5 Dec 2014

  Activity: Talk or presentation › Conference presentation

• Polycomb regulates the homeostasis of the small intestinal epithelium along the crypt-villus axis - aberrancies implicated in celiac disease

  Keijo Viiri (Contributor), Kalle Kurppa (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor), Mikko Oittinen (Contributor) & Alina Popp (Contributor)

  28 Oct 2014

  Activity: Talk or presentation › Conference presentation

• Genetic variation of genes CCL25 and CCR9 in celiac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  1 Aug 2014

  Activity: Talk or presentation › Conference presentation

• The induction of early developing celiac disease in mice by injection of celiac disease patient sera or immunoglobulins

  Suvi Kalliokoski (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  1 Jul 2014

  Activity: Talk or presentation › Conference presentation

• Coeliac disease and immunoglobulin IgA nephropathy : the missing link

  Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor), Jukka Mustonen (Contributor) & Markku Mäki (Contributor)

  10 Jun 2014

  Activity: Talk or presentation › Conference presentation

• Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics

  Suvi Kalliokoski (Contributor), Ana-Marija Sulic (Contributor), Ilma R. Korponay-Szabó (Contributor), Zsuzsa Szondy (Contributor), Rafael Frias (Contributor), Mileidys Alea Perez (Contributor), Stefania Martucciello (Contributor), Anne Roivainen (Contributor), Lauri J. Pelliniemi (Contributor), Carla Esposito (Contributor), Martin Griffin (Contributor), Sblattero Daniele (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Sergio Caja (Contributor)

  13 Feb 2014

  Activity: Talk or presentation › Conference presentation

• Injection of celiac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma Korponay-Szabó (Contributor), Rafael Frias (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  17 Dec 2013

  Activity: Talk or presentation › Conference presentation

• Sequencing CCR9 and CCL25 genes in celiac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  17 Dec 2013

  Activity: Talk or presentation › Conference presentation

• Does coeliac patient IgA have similar cellular effects regardless of the disease stage or type of manifestation?

  Minna Hietikko (Contributor), Pekka Collin (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Timo Reunala (Contributor)

  17 Dec 2013

  Activity: Talk or presentation › Conference presentation

• Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation

  Cristina Nadalutti (Contributor), Ilma Korponay-Szabó (Contributor), Katri Kaukinen (Contributor), Wang Zhuo (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor) & K Lindfors (Contributor)

  25 Sept 2013

  Activity: Talk or presentation › Conference presentation

• Celiac disease patient IgA mediates endothelial adhesion and cell polarization defects via extracellular transglutaminase 2

  Cristina Nadalutti (Contributor), Ilma Korponay-Szabó (Contributor), Katri Kaukinen (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  25 Sept 2013

  Activity: Talk or presentation › Conference presentation

• Epithelial integrity in the duodenal mucosa is compromised in early stages of celiac disease

  Tiina Rauhavirta (Contributor), Minna Hietikko (Contributor), Katri Lindfors (Contributor), Outi Koskinen (Contributor), Kaija Laurila (Contributor), Kalle Kurppa (Contributor), Päivi Saavalainen (Contributor), Markku Mäki (Contributor), Pekka Collin (Contributor) & Katri Kaukinen (Contributor)

  25 Sept 2013

  Activity: Talk or presentation › Conference presentation

• Characterization of cellular alterations in the small bowel mucosa in non-celiac gluten sensitivity

  Mikko Oittinen (Speaker), Katri Lindfors (Speaker), Kaija Laurila (Speaker), Outi Koskinen (Speaker), Timo Reunala (Speaker), Markku Mäki (Speaker), Pekka Collin (Speaker) & Katri Kaukinen (Speaker)

  24 Sept 2013

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Speaker), Sergio Caja Galan (Speaker), Katri Kaukinen (Speaker), Ilma Korponay-Szabó (Speaker), Katri Lindfors (Speaker) & Markku Mäki (Speaker)

  23 Sept 2013

  Activity: Talk or presentation › Conference presentation

• A new method for long-term culturing of intestinal biopsies derived from coeliac disease patients using mice as carriers

  Markku Mäki (Contributor), Sergio Caja Galan (Contributor), Ilma Korponay-Szabó (Contributor) & Katri Lindfors (Contributor)

  23 Sept 2013

  Activity: Talk or presentation › Conference presentation

• Chemokine receptor CCR9 and its ligand CCL25 in celiac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  23 Sept 2013

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  11 Jun 2013

  Activity: Talk or presentation › Conference presentation

• Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2

  B Tóth (Contributor), R Bogáti (Contributor), R Király (Contributor), Z Simon-Vecsei (Contributor), Sergio Caja Galan (Contributor), B Barta-Tóth (Contributor), C Nadalutti (Contributor), K Lindfors (Contributor), M Mäki (Contributor), L Fésüs (Contributor) & I Korponay-Szabo (Contributor)

  10 May 2013

  Activity: Talk or presentation › Conference presentation

• The expression of epithelial junction proteins is decreased already in early developing coeliac disease and negatively correlates with diarrhea

  Katri Lindfors (Speaker), Pekka Collin (Speaker), Katri Kaukinen (Speaker), Kaija Laurila (Speaker), Markku Mäki (Speaker) & Tiina Rauhavirta (Speaker)

  9 May 2013

  Activity: Talk or presentation › Conference presentation

• The expression of epithelial junction proteins is decreased in early developing coeliac disease and negatively correlates with diarrhoea

  Tiina Rauhavirta (Contributor), Pekka Collin (Contributor), Katri Kaukinen (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  14 Feb 2013

  Activity: Talk or presentation › Conference presentation

• Celiac disease–specific TG2-targeted autoantibodies inhibit angiogenesis in vivo in mice by modulating extracellular matrix

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Ana-Marija Sulic (Contributor)

  14 Feb 2013

  Activity: Talk or presentation › Conference presentation

• A new method for culturing intestinal biopsies derived from coeliac disease patients using a mouse model

  Markku Mäki (Contributor), Sergio Caja Galan (Contributor), Ilma Korponay-Szabó (Contributor) & Katri Lindfors (Contributor)

  14 Feb 2013

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  18 Dec 2012

  Activity: Talk or presentation › Conference presentation

• A new method for culturing intestinal biopsies derived from coeliac disease patients using a mouse model

  Emily McKinney (Contributor), Sergio Caja Galan (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  18 Dec 2012

  Activity: Talk or presentation › Conference presentation

• The expression of epithelial junction proteins is decreased already in early developing coeliac disease and negatively correlates with diarrhoea

  Tiina Rauhavirta (Contributor), Katri Lindfors (Contributor), Kaija Laurila (Contributor), Markku Mäki (Contributor), Pekka Collin (Contributor) & Katri Kaukinen (Contributor)

  18 Dec 2012

  Activity: Talk or presentation › Conference presentation

• Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population

  Amarjit Singh Parmar (Contributor), Noora Alakulppi (Contributor), Paulina Paavola-Sakki (Contributor), Kalle Kurppa (Contributor), Leena Halme (Contributor), Martti Färkkilä (Contributor), Ulla Turunen (Contributor), Maarit Lappalainen (Contributor), Kimmo Kontula (Contributor), Katri Kaukinen (Contributor), Markku Mäki (Contributor), Katri Lindfors (Contributor), Jukka Partanen (Contributor), Pertti Sistonen (Contributor), Jaana Mättö (Contributor), Pirjo Wacklin (Contributor), Päivi Saavalainen (Contributor) & Elisabet Einarsdottir (Contributor)

  17 Sept 2012

  Activity: Talk or presentation › Conference presentation

• A new method for culturing intestinal biopsies derived from coeliac disease patients using a mouse model

  Emily McKinney (Contributor), Boglarka Toth (Contributor), Markku Maki (Contributor), Katri Lindfors (Contributor), Ilma Korponay-Szabo (Contributor) & Sergio Caja (Contributor)

  8 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb vessel morphogenesis in vitro and in vivo through RhoB

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor), Cristina Nadalutti (Contributor), Tiina Rauhavirta (Contributor) & Ana-Marija Sulic (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Celiac disease-specific autoantibodies targeted against transglutaminase 2 disturb vessel morphogenesis in vitro and in vivo through RhoB

  Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor), Cristina Nadalutti (Contributor) & Tiina Rauhavirta (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• The duodenal microbiota composition of adult coeliac disease patients differs between various disease outcomes

  Pirjo Wacklin (Contributor), Katri Kaukinen (Contributor), Elina Tuovinen (Contributor), Pekka Collin (Contributor), Katri Lindfors (Contributor), Jukka Partanen (Contributor), Markku Mäki (Contributor) & Jaana Mättö (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• The effects of TG2 inhibitors on gliadin-induced toxicity – implications for future coeliac disease therapy

  Tiina Rauhavirta (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Mikko Oittinen (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Transglutaminase 2 and thioredoxin : current research in celiac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Markku Mäki (Contributor), Russell Collighan (Contributor), Martin Griffin (Contributor) & Katri Lindfors (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Transglutaminase 2 and thioredoxin: current research in celiac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  16 Jul 2012

  Activity: Talk or presentation › Conference presentation

• Injection of celiac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma R. Korponay-Szabó (Contributor), Rafael Frias (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  16 Jul 2012

  Activity: Talk or presentation › Conference presentation

• Association of FUT2 (rs601338) with celiac disease in Finnish patients

  A Parmar (Contributor), N Alakulppi (Contributor), E Einarsdottir (Contributor), K Kaukinen (Contributor), K Kurppa (Contributor), M Mäki (Contributor), K Lindfors (Contributor), J Partanen (Contributor), K Aranko (Contributor), J Mättö (Contributor), P Wacklin (Contributor) & P Saavalainen (Contributor)

  25 Jun 2012

  Activity: Talk or presentation › Conference presentation

• Association of FUT2 (RS601338) with celiac disease in the Finnish population

  Katri Lindfors (Contributor), Katri Kaukinen (Contributor), Kalle Kurppa (Contributor) & Markku Mäki (Contributor)

  7 Jun 2012

  Activity: Talk or presentation › Conference presentation

• The effects of TG2 inhibitors on gliadin-induced toxicity - implications for future coeliac disease therapy

  Tiina Rauhavirta (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Mikko Oittinen (Contributor)

  7 Jun 2012

  Activity: Talk or presentation › Conference presentation

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Johanna Schleutker (Contributor), Päivi Saavalainen (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  7 Jun 2012

  Activity: Talk or presentation › Conference presentation

• Passive transfer of celiac patient serum or purified serum immunoglobulins induce features of early developing celiac disease in mice

  Katri Lindfors (Speaker), Sergio Caja Galan (Speaker), Suvi Kalliokoski (Speaker), Katri Kaukinen (Speaker), Ilma Korponay-Szabó (Speaker) & Markku Mäki (Speaker)

  11 May 2012

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma Korponay-Szabó (Contributor), Rafael Frias (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  27 Apr 2012

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Speaker), Sergio Caja (Speaker), Ilma R. Korponay-Szabó (Speaker), Rafael Frias (Speaker), Outi Koskinen (Speaker), Markku Mäki (Speaker), Katri Kaukinen (Speaker) & Katri Lindfors (Speaker)

  9 Feb 2012

  Activity: Talk or presentation › Conference presentation

• Genetic background of coeliac disease - chemokine receptor CCR9 and its ligand CCL25

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  9 Feb 2012

  Activity: Talk or presentation › Conference presentation

• Transglutaminase 2 and thioredoxin : current research in celiac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  9 Feb 2012

  Activity: Talk or presentation › Conference presentation

• The effects of TG2 inhibitors on gliadin-induced toxicity - implications for future coeliac disease therapy

  Tiina Rauhavirta (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Mikko Oittinen (Contributor)

  9 Feb 2012

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  15 Dec 2011

  Activity: Talk or presentation › Conference presentation

• The effects of TG2 inhibitors on gliadin-induced toxicity: Implications for future coeliac disease therapy

  Tiina Rauhavirta (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  15 Dec 2011

  Activity: Talk or presentation › Conference presentation

• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb vessel morphogenesis in vitro and in vivo through RhoB

  Suvi Kallikoski (Speaker), Cristina Nadalluti (Speaker), Tina Rauhavista (Speaker), Ana-Marija Sulic (Speaker), Markku Mäki (Speaker), Katri Kaukinen (Speaker) & Katri Lindfors (Speaker)

  15 Dec 2011

  Activity: Talk or presentation › Conference presentation

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Johanna Schleutker (Contributor), Päivi Saavalainen (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  15 Dec 2011

  Activity: Talk or presentation › Conference presentation

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Johanna Schleutker (Contributor)

  22 Nov 2011

  Activity: Talk or presentation › Conference presentation